Vanessa Alvarado
Family · Sarasota, FLNPI 1457907867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 26.3% of the total. Reporting peaked in 2022 at $2,220 and has fallen 95.3% since, to $105 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $24.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Relievant Medsystems, Inc.$683
- Nevro Corp.$300
- Almatica Pharma LLC$254
- Boston Scientific$239
- GRT US Holding, Inc.$218
- plus $2K from 27 others
What the payments were for
- Travel & lodging$2365%
- Food & beverage$4,95895%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $1,363 |
| Relievant Medsystems, Inc. | 7 | $683 |
| Nevro Corp. | 15 | $300 |
| Almatica Pharma LLC | 14 | $254 |
| Boston Scientific | 10 | $239 |
| GRT US Holding, Inc. | 10 | $218 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $212 |
| Collegium Pharmaceutical, Inc. | 9 | $189 |
| IBSA Pharma Inc. | 11 | $183 |
| Pfizer | 9 | $174 |
| Biohaven Pharmaceuticals, Inc. | 6 | $166 |
| Pacira Pharmaceuticals Incorporated | 3 | $163 |
| Centinel Spine, LLC | 2 | $151 |
| Averitas Pharma Inc. | 7 | $147 |
| Teva Pharmaceuticals USA, Inc. | 5 | $98 |
| Amgen | 4 | $87 |
| Medtronic | 4 | $72 |
| Avanos Medical | 3 | $71 |
| Tersera Therapeutics LLC | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 3 | $54 |
| Scilex Pharmaceuticals Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Nalu Medical, Inc. | 2 | $31 |
| Smith+Nephew | 2 | $31 |
| SPR Therapeutics, Inc | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Orthogenrx Inc. | 1 | $18 |
| MVP Orthopedics Inc | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| MDD US Operations, LLC | 1 | $12 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,329
- PRODISC C SK$133
- UBRELVY$124
- Iovera$122
- BOTOX$109
How this compares
$5,194 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 108 | $1,789 |
| Duloxetine Hcl | 40 | $791 |
| Tizanidine Hcl | 40 | $446 |
| Celecoxib | 15 | $183 |
| Cyclobenzaprine Hcl | 14 | $178 |
| Methocarbamol | 15 | $63 |
Paid to pharmacies, not to this prescriber.
Other family in Sarasota
- Marie ZambelliSarasota$65K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.